Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The person must agree to take part and sign a consent form
- There must be a blockage in one of the major blood vessels supplying the brain, confirmed by a special scan (CTA or MRA), in specific locations in the front or back part of the brain's blood supply
- A brain scan must show a score of 6 or higher on a measure used to assess how much of the brain may still be saved (confirm with trial site)
- Scans must show that some brain tissue can still be rescued, either through a "mismatch" pattern or by showing that good backup blood flow pathways exist
- The procedure to treat the blockage must begin within 12 hours of symptoms first starting
- A specific medical device called the EmboTrap® II Revascularization Device must be used as the first or second treatment attempt to remove the blockage
Who may not be able to join:
- People who have not given their consent to take part
- People who have a blockage in a blood vessel outside the brain, or a combination of blockages in both the neck and brain vessels (called a tandem occlusion)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 00396444
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety: device -related haemorrhages rate showed by CT/MR; Efficacy: Restoration of cerebral blood flow at the end of the procedure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.